FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136246782> ?p ?o ?g. }

• W3136246782 endingPage "786" @default.
• W3136246782 startingPage "783" @default.
• W3136246782 abstract "NanomedicineVol. 16, No. 10 CommentaryApplications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseasesYinghan Chan, Parteek Prasher, Raimar Löbenberg, Gaurav Gupta, Sachin Kumar Singh, Brian G Oliver, Dinesh Kumar Chellappan & Kamal DuaYinghan Chan https://orcid.org/0000-0001-8405-8637School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur 57000, MalaysiaSearch for more papers by this author, Parteek Prasher https://orcid.org/0000-0002-9412-9424Department of Chemistry, University of Petroleum & Energy Studies, Energy Acres, Dehradun 248007, IndiaSearch for more papers by this author, Raimar Löbenberg https://orcid.org/0000-0002-0919-0213University of Alberta, Faculty of Pharmacy & Pharmaceutical Sciences, Edmonton, AB T6G 2N8, CanadaSearch for more papers by this author, Gaurav Gupta https://orcid.org/0000-0001-7941-0229School of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Jaipur 302017, IndiaSearch for more papers by this author, Sachin Kumar Singh https://orcid.org/0000-0003-3823-6572School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab 144411, IndiaSearch for more papers by this author, Brian G Oliver https://orcid.org/0000-0002-7122-9262School of Life Sciences, Faculty of Science, University of Technology, Sydney NSW 2007, AustraliaWoolcock Institute of Medical Research, University of Sydney, Sydney, NSW, AustraliaSearch for more papers by this author, Dinesh Kumar Chellappan *Author for correspondence: E-mail Address: Dinesh_Kumar@imu.edu.myhttps://orcid.org/0000-0001-5567-6663Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur 57000, MalaysiaSearch for more papers by this author & Kamal Dua **Author for correspondence: Tel.: +61 295 147 387; E-mail Address: Kamal.Dua@uts.edu.auhttps://orcid.org/0000-0002-7507-1159University of Alberta, Faculty of Pharmacy & Pharmaceutical Sciences, Edmonton, AB T6G 2N8, CanadaDiscipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, AustraliaPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW 2305, AustraliaSearch for more papers by this authorPublished Online:18 Mar 2021https://doi.org/10.2217/nnm-2021-0056AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: drug deliverynanomaterialspulmonary diseaseToll-like receptorsReferences1. Labaki WW, Han MLK. Chronic respiratory diseases: a global view. Lancet Respir. Med. 8(6), 531–533 (2020).Crossref, Medline, Google Scholar2. Chan Y, Ng SW, Mehta M, Gupta G, Chellappan DK, Dua K. Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld. Future Med. Chem. 12(21), 1887–1890 (2020).Crossref, Medline, CAS, Google Scholar3. Kovach MA, Standiford TJ. Toll-like receptors in diseases of the lung. Int. Immunopharmacol. 11(10), 1399–1406 (2011).Crossref, Medline, CAS, Google Scholar4. Chan Y, Ng SW, Mehta M et al. Advanced drug delivery systems can assist in managing influenza virus infection: a hypothesis. Med. Hypotheses 144, 110298 (2020).Crossref, Medline, CAS, Google Scholar5. Vasilichin VA, Tsymbal SA, Fakhardo AF et al. Effects of metal oxide nanoparticles on Toll-like receptor mRNAs in human monocytes. Nanomaterials (Basel). 10(1), 127 (2020).Crossref, CAS, Google Scholar6. Arora S, Ahmad S, Irshad R et al. TLRs in pulmonary diseases. Life Sci. 233, 116671 (2019).Crossref, Medline, CAS, Google Scholar7. Lafferty EI, Qureshi ST, Schnare M. The role of Toll-like receptors in acute and chronic lung inflammation. J. Inflamm. (Lond). 7(1), 1–14 (2010).Crossref, Medline, Google Scholar8. Gao W, Xiong Y, Li Q, Yang H. Inhibition of Toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics. Front. Physiol. 8, 508 (2017).Crossref, Medline, Google Scholar9. Zuo L, Lucas K, Fortuna CA, Chuang CC, Best TM. Molecular regulation of Toll-like receptors in asthma and COPD. Front. Physiol. 6, 312 (2015).Crossref, Medline, Google Scholar10. Sidletskaya K, Vitkina T, Denisenko Y. The role of Toll-like receptors 2 and 4 in the pathogenesis of chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 15, 1481–1493 (2020).Crossref, Medline, CAS, Google Scholar11. Haw TJ, Starkey MR, Pavlidis S et al. Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 314(2), L298–L317 (2018).Medline, CAS, Google Scholar12. An CH, Wang XM, Lam HC et al. TLR4 deficiency promotes autophagy during cigarette smoke-induced pulmonary emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol. 303(9), L748–L757 (2012).Crossref, Medline, CAS, Google Scholar13. Gu J, Liu Y, Xie B, Ye P, Huang J, Lu Z. Roles of Toll-like receptors: from inflammation to lung cancer progression (Review). Biomed. Rep. 8(2), 126–132 (2018).Medline, CAS, Google Scholar14. Javaid N, Yasmeen F, Choi S. Toll-like receptors and relevant emerging therapeutics with reference to delivery methods. Pharmaceutics 11(9), 441 (2019).Crossref, CAS, Google Scholar15. Perry JL, Tian S, Sengottuvel N et al. Pulmonary delivery of nanoparticle-bound Toll-like receptor 9 agonist for the treatment of metastatic lung cancer. ACS Nano 14(6), 7200–7215 (2020).Crossref, Medline, CAS, Google Scholar16. Nigar S, Yamamato Y, Okajima T et al. Synergistic oligodeoxynucleotide strongly promotes CpG-induced interleukin-6 production. BMC Immunol. 18(1), 1–9 (2017).Crossref, Medline, Google Scholar17. Shan H, Dou W, Zhang Y, Qi M. Targeted ferritin nanoparticle encapsulating CpG oligodeoxynucleotides induces tumor-associated macrophage M2 phenotype polarization into M1 phenotype and inhibits tumor growth. Nanoscale 12(43), 22268–22280 (2020).Crossref, Medline, CAS, Google Scholar18. Babazada H, Yamashita F, Yanamoto S, Hashida M. Self-assembling lipid modified glycol-split heparin nanoparticles suppress lipopolysaccharide-induced inflammation through TLR4-NF-κB signaling. J. Control Release 194, 332–340 (2014).Crossref, Medline, CAS, Google Scholar19. Yang H, Fung SY, Xu S et al. Amino acid-dependent attenuation of Toll-like receptor signaling by peptide-gold nanoparticle hybrids. ACS Nano 9(7), 6774–6784 (2015).Crossref, Medline, CAS, Google Scholar20. Foit L, Thaxton CS. Synthetic high-density lipoprotein-like nanoparticles potently inhibit cell signaling and production of inflammatory mediators induced by lipopolysaccharide binding Toll-like receptor 4. Biomaterials 100, 67–75 (2016).Crossref, Medline, CAS, Google ScholarFiguresReferencesRelatedDetailsCited ByRevolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspectiveLife Sciences, Vol. 280 Vol. 16, No. 10 Follow us on social media for the latest updates Metrics Downloaded 74 times History Received 12 February 2021 Accepted 24 February 2021 Published online 18 March 2021 Published in print April 2021 Information© 2021 Future Medicine LtdKeywordsdrug deliverynanomaterialspulmonary diseaseToll-like receptorsFinancial & competing interests disclosureThe authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received, or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download" @default.
• W3136246782 created "2021-03-29" @default.
• W3136246782 creator A5014175346 @default.
• W3136246782 creator A5029044461 @default.
• W3136246782 creator A5040015789 @default.
• W3136246782 creator A5044372095 @default.
• W3136246782 creator A5047815558 @default.
• W3136246782 creator A5061337632 @default.
• W3136246782 creator A5073251236 @default.
• W3136246782 creator A5074742233 @default.
• W3136246782 date "2021-04-01" @default.
• W3136246782 modified "2023-09-24" @default.
• W3136246782 title "Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases" @default.
• W3136246782 cites W1966908189 @default.
• W3136246782 cites W2005455680 @default.
• W3136246782 cites W2044780100 @default.
• W3136246782 cites W2157494890 @default.
• W3136246782 cites W2165410977 @default.
• W3136246782 cites W2397385450 @default.
• W3136246782 cites W2406928924 @default.
• W3136246782 cites W2737868829 @default.
• W3136246782 cites W2763963021 @default.
• W3136246782 cites W2963707514 @default.
• W3136246782 cites W2970061921 @default.
• W3136246782 cites W3000694578 @default.
• W3136246782 cites W3030724974 @default.
• W3136246782 cites W3033851921 @default.
• W3136246782 cites W3036540280 @default.
• W3136246782 cites W3087996050 @default.
• W3136246782 cites W3093308483 @default.
• W3136246782 cites W3097547374 @default.
• W3136246782 doi "https://doi.org/10.2217/nnm-2021-0056" @default.
• W3136246782 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33733817" @default.
• W3136246782 hasPublicationYear "2021" @default.
• W3136246782 type Work @default.
• W3136246782 sameAs 3136246782 @default.
• W3136246782 citedByCount "6" @default.
• W3136246782 countsByYear W31362467822021 @default.
• W3136246782 countsByYear W31362467822022 @default.
• W3136246782 countsByYear W31362467822023 @default.
• W3136246782 crossrefType "journal-article" @default.
• W3136246782 hasAuthorship W3136246782A5014175346 @default.
• W3136246782 hasAuthorship W3136246782A5029044461 @default.
• W3136246782 hasAuthorship W3136246782A5040015789 @default.
• W3136246782 hasAuthorship W3136246782A5044372095 @default.
• W3136246782 hasAuthorship W3136246782A5047815558 @default.
• W3136246782 hasAuthorship W3136246782A5061337632 @default.
• W3136246782 hasAuthorship W3136246782A5073251236 @default.
• W3136246782 hasAuthorship W3136246782A5074742233 @default.
• W3136246782 hasConcept C104863432 @default.
• W3136246782 hasConcept C127413603 @default.
• W3136246782 hasConcept C144133560 @default.
• W3136246782 hasConcept C161191863 @default.
• W3136246782 hasConcept C162324750 @default.
• W3136246782 hasConcept C162853370 @default.
• W3136246782 hasConcept C187736073 @default.
• W3136246782 hasConcept C3018591125 @default.
• W3136246782 hasConcept C41008148 @default.
• W3136246782 hasConcept C512399662 @default.
• W3136246782 hasConcept C71924100 @default.
• W3136246782 hasConceptScore W3136246782C104863432 @default.
• W3136246782 hasConceptScore W3136246782C127413603 @default.
• W3136246782 hasConceptScore W3136246782C144133560 @default.
• W3136246782 hasConceptScore W3136246782C161191863 @default.
• W3136246782 hasConceptScore W3136246782C162324750 @default.
• W3136246782 hasConceptScore W3136246782C162853370 @default.
• W3136246782 hasConceptScore W3136246782C187736073 @default.
• W3136246782 hasConceptScore W3136246782C3018591125 @default.
• W3136246782 hasConceptScore W3136246782C41008148 @default.
• W3136246782 hasConceptScore W3136246782C512399662 @default.
• W3136246782 hasConceptScore W3136246782C71924100 @default.
• W3136246782 hasIssue "10" @default.
• W3136246782 hasLocation W31362467821 @default.
• W3136246782 hasOpenAccess W3136246782 @default.
• W3136246782 hasPrimaryLocation W31362467821 @default.
• W3136246782 hasRelatedWork W1923367337 @default.
• W3136246782 hasRelatedWork W1975067875 @default.
• W3136246782 hasRelatedWork W2079280342 @default.
• W3136246782 hasRelatedWork W2267700835 @default.
• W3136246782 hasRelatedWork W2461190787 @default.
• W3136246782 hasRelatedWork W2610092268 @default.
• W3136246782 hasRelatedWork W3209723265 @default.
• W3136246782 hasRelatedWork W4200154812 @default.
• W3136246782 hasRelatedWork W780252691 @default.
• W3136246782 hasRelatedWork W2276127806 @default.
• W3136246782 hasVolume "16" @default.
• W3136246782 isParatext "false" @default.
• W3136246782 isRetracted "false" @default.
• W3136246782 magId "3136246782" @default.
• W3136246782 workType "article" @default.